Found: 128
Select item for more details and to access through your institution.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 152, doi. 10.1007/s10637-020-00942-1
- By:
- Publication type:
- Article
Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 468, doi. 10.1007/s10637-019-00787-3
- By:
- Publication type:
- Article
Global trends in the distribution of cancer types among patients in oncology phase I trials, 1991-2015.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 166, doi. 10.1007/s10637-018-0654-1
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF<sup>V600</sup> mutation-positive solid tumors: a phase 1 study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 259, doi. 10.1007/s10637-017-0502-8
- By:
- Publication type:
- Article
Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 392, doi. 10.1007/s10637-017-0434-3
- By:
- Publication type:
- Article
Phase Ia/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 1, p. 37, doi. 10.1007/s10637-016-0382-3
- By:
- Publication type:
- Article
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 596, doi. 10.1007/s10637-016-0371-6
- By:
- Publication type:
- Article
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 66, doi. 10.1007/s10637-015-0300-0
- By:
- Publication type:
- Article
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 4, p. 881, doi. 10.1007/s10637-015-0243-5
- By:
- Publication type:
- Article
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 641, doi. 10.1007/s10637-015-0229-3
- By:
- Publication type:
- Article
Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1158, doi. 10.1007/s10637-013-9959-2
- By:
- Publication type:
- Article
Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 293, doi. 10.1007/s10637-012-9855-1
- By:
- Publication type:
- Article
Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 1950, doi. 10.1007/s10637-011-9751-0
- By:
- Publication type:
- Article
Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1352, doi. 10.1007/s10637-011-9699-0
- By:
- Publication type:
- Article
Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1055, doi. 10.1007/s10637-011-9637-1
- By:
- Publication type:
- Article
Efficacy of surgery for skin cancers initially suspected to be carcinoma of unknown primary: a retrospective observational study.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 4, p. e150, doi. 10.1111/ijd.15707
- By:
- Publication type:
- Article
The Changes of Serotonin (5HT-1, 5HT-1A, 5HT-1B, 5HT-2) Receptor Densities in Rat Brain Following Chronic Zotepine Treatment.
- Published in:
- Psychiatry & Clinical Neurosciences, 1986, v. 40, n. 2, p. 231, doi. 10.1111/j.1440-1819.1986.tb03146.x
- By:
- Publication type:
- Article
Intermetallic phase formation in electrochemical alloy deposition.
- Published in:
- Journal of Solid State Electrochemistry, 2004, v. 8, n. 3, p. 167, doi. 10.1007/s10008-003-0441-5
- By:
- Publication type:
- Article
Autochthonous experience, heightened awareness, and perception distortion in patients with schizophrenia: a symptomatological study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2004, v. 58, n. 5, p. 473, doi. 10.1111/j.1440-1819.2004.01288.x
- By:
- Publication type:
- Article
Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders.
- Published in:
- Psychiatry & Clinical Neurosciences, 1999, v. 53, p. S67
- By:
- Publication type:
- Article
Effect of chronic ipsapirone treatment on the density of 5-HT<sub>1A</sub> receptors and 5-HT<sub>1A</sub> receptor mRNA in discrete regions of the rat brain.
- Published in:
- Psychiatry & Clinical Neurosciences, 1996, v. 50, n. 3, p. 141, doi. 10.1111/j.1440-1819.1996.tb01679.x
- By:
- Publication type:
- Article
Lack of Effect of Haloperidol or Methamphetamine Treatment on the mRNA Levels of Two Dopamine D, Receptor Isoforms in Rat Brain.
- Published in:
- Psychiatry & Clinical Neurosciences, 1992, v. 46, n. 4, p. 967, doi. 10.1111/j.1440-1819.1992.tb02868.x
- By:
- Publication type:
- Article
Voluntary Intake of Alcohol Is Attenuated by Ipsapirone in Mice and Role of 5-HT<sub>1A</sub> Receptor.
- Published in:
- Psychiatry & Clinical Neurosciences, 1992, v. 46, n. 1, p. 197, doi. 10.1111/j.1440-1819.1992.tb00834.x
- By:
- Publication type:
- Article
Localization of the mRNAs for Two Dopamine D<sub>2</sub> Receptor Isoforms in the Rat Brain.
- Published in:
- Psychiatry & Clinical Neurosciences, 1991, v. 45, n. 4, p. 897, doi. 10.1111/j.1440-1819.1991.tb00530.x
- By:
- Publication type:
- Article
The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 613, doi. 10.1007/s00228-022-03275-5
- By:
- Publication type:
- Article
Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma.
- Published in:
- Rare Tumors, 2010, v. 2, n. 3, p. 151, doi. 10.4081/rt.2010.e53
- By:
- Publication type:
- Article
Correction to: Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 12, p. 1585, doi. 10.1007/s10147-023-02414-x
- By:
- Publication type:
- Article
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 10, p. 1315, doi. 10.1007/s10147-023-02382-2
- By:
- Publication type:
- Article
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 217, doi. 10.1007/s10147-019-01498-8
- By:
- Publication type:
- Article
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 4, p. 780, doi. 10.1007/s10147-017-1108-z
- By:
- Publication type:
- Article
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3185, doi. 10.1007/s00432-022-04205-9
- By:
- Publication type:
- Article
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1292, doi. 10.1634/theoncologist.2020-0249
- By:
- Publication type:
- Article
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
- Published in:
- Oncologist, 2016, v. 21, n. 2, p. 156, doi. 10.1634/theoncologist.2015-0288
- By:
- Publication type:
- Article
Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 20, p. 7418, doi. 10.1002/cam4.3385
- By:
- Publication type:
- Article
Risk factors for pneumonitis in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 5, p. 724, doi. 10.1111/1759-7714.14308
- By:
- Publication type:
- Article
Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113259
- By:
- Publication type:
- Article
Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104215
- By:
- Publication type:
- Article
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non–small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 3, p. 261, doi. 10.1007/s10637-024-01422-6
- By:
- Publication type:
- Article
The genomic and epigenomic landscape in thymic carcinoma.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 11, p. 1084, doi. 10.1093/carcin/bgx094
- By:
- Publication type:
- Article
FIGHT‐102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10597, doi. 10.1002/cam4.5798
- By:
- Publication type:
- Article
Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2350, doi. 10.1002/cam4.3815
- By:
- Publication type:
- Article
Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00113
- By:
- Publication type:
- Article
Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00301
- By:
- Publication type:
- Article
Clinical characteristics of adrenal insufficiency as an immune-related adverse event in non-small-cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article